← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Boston Biotechnology Corporation
Watertown, MA
$2,964,430
Total funding
4
Grants
Funding over time
peak $507.4K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$2,964,430 · 4
By mechanism
R44$2,666,787 · 3
R43$297,643 · 1
Investigators at Boston Biotechnology Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
IMMUNOTHERAPY OF ALZHEIMER'S DISEASE$378,083
R44 · FY2000 · AG
EPITOPE-SPECIFIC ANTIBODIES FOR ALZHEIMER'S DISEASE$374,937
R44 · FY2004 · AG
EPITOPE-SPECIFIC ANTIBODIES FOR ALZHEIMER'S DISEASE$374,937
R44 · FY2005 · AG
GHRELIN VACCINES FOR CONTROLLING OBESITY$374,937
R44 · FY2006 · DK
GHRELIN VACCINES FOR CONTROLLING OBESITY$374,937
R44 · FY2007 · DK
IMMUNOTHERAPY OF ALZHEIMER'S DISEASE$348,695
R44 · FY2001 · AG
HTS for Protein Splicing Inhibitors as TB Drugs$297,643
R43 · FY2003 · AI
IMMUNOTHERAPY OF ALZHEIMER'S DISEASE$133,750
R44 · FY2003 · AG
EPITOPE-SPECIFIC ANTIBODIES FOR ALZHEIMER'S DISEASE$132,413
R44 · FY2006 · AG
EPITOPE-SPECIFIC ANTIBODIES FOR ALZHEIMER'S DISEASE$100,000
R44 · FY2003 · AG
GHRELIN VACCINES FOR CONTROLLING OBESITY$74,098
R44 · FY2005 · DK